These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 12352185)

  • 1. Neuroendocrine marker expression in cervical carcinomas of non-small cell type.
    Chavez-Blanco A; Taja-Chayeb L; Cetina L; Chanona-Vilchis G; Trejo-Becerril C; Perez-Cardenas E; Segura-Pacheco B; Acuña-González C; Dueñas-Gonzalez A
    Int J Gynecol Pathol; 2002 Oct; 21(4):368-74. PubMed ID: 12352185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spectrum of neuroendocrine carcinomas of the uterine cervix, including histopathologic features, terminology, immunohistochemical profile, and clinical outcomes in a series of 50 cases from a single institution in India.
    Rekhi B; Patil B; Deodhar KK; Maheshwari A; A Kerkar R; Gupta S; Tongaonkar HB; Shrivastava SK
    Ann Diagn Pathol; 2013 Feb; 17(1):1-9. PubMed ID: 22534245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small cell carcinoma of the uterine cervix--an uncommon variant of cervical cancer with neuroendocrine features.
    Lenczewski A; Terlikowski S; Sulkowska M; Famulski W; Kisielewski W; Kulikowski M
    Folia Histochem Cytobiol; 2001; 39 Suppl 2():89-90. PubMed ID: 11820641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of neuron-specific enolase, chromogranin A, synaptophysin and Leu-7 in lung cancer cell lines.
    Poola I; Graziano SL
    J Exp Clin Cancer Res; 1998 Jun; 17(2):165-73. PubMed ID: 9700577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secretagogin is a new neuroendocrine marker in the human prostate.
    Adolf K; Wagner L; Bergh A; Stattin P; Ottosen P; Borre M; Birkenkamp-Demtröder K; Orntoft TF; Tørring N
    Prostate; 2007 Apr; 67(5):472-84. PubMed ID: 17285592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selected markers (chromogranin A, neuron-specific enolase, synaptophysin, protein gene product 9.5) in diagnosis and prognosis of neuroendocrine pulmonary tumours.
    Kasprzak A; Zabel M; Biczysko W
    Pol J Pathol; 2007; 58(1):23-33. PubMed ID: 17585539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroendocrine differentiation in colorectal carcinomas.
    Syversen U; Halvorsen T; Mårvik R; Waldum HL
    Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):667-74. PubMed ID: 8590163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between chromogranin A, neuron-specific enolase and synaptophysin expression, and some clinico-pathological features of colorectal cancer.
    Famulski W; Sulkowska M; Miller-Famulska D; Kisielewski W; Sulkowski S
    Folia Histochem Cytobiol; 2001; 39(2):155-6. PubMed ID: 11374802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromogranin A as serum marker for neuroendocrine neoplasia: comparison with neuron-specific enolase and the alpha-subunit of glycoprotein hormones.
    Nobels FR; Kwekkeboom DJ; Coopmans W; Schoenmakers CH; Lindemans J; De Herder WW; Krenning EP; Bouillon R; Lamberts SW
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2622-8. PubMed ID: 9253344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroendocrine carcinomas of the uterine cervix: A clinicopathological study.
    Sitthinamsuwan P; Angkathunyakul N; Chuangsuwanich T; Inthasorn P
    J Med Assoc Thai; 2013 Jan; 96(1):83-90. PubMed ID: 23720983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of neuroendocrine differentiation markers in lethal metastatic castration-resistant prostate cancer.
    Sainio M; Visakorpi T; Tolonen T; Ilvesaro J; Bova GS
    Pathol Res Pract; 2018 Jun; 214(6):848-856. PubMed ID: 29728311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroendocrine differentiation in cervical carcinoma.
    Savargaonkar PR; Hale RJ; Mutton A; Manning V; Buckley CH
    J Clin Pathol; 1996 Feb; 49(2):139-41. PubMed ID: 8655680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroendocrine expression in metastatic prostate cancer: evaluation of high throughput tissue microarrays to detect heterogeneous protein expression.
    Mucci NR; Akdas G; Manely S; Rubin MA
    Hum Pathol; 2000 Apr; 31(4):406-14. PubMed ID: 10821485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic significance of circulating neuroendocrine markers chromogranin a, pro-gastrin-releasing peptide and neuron-specific enolase in patients with advanced non-small-cell lung cancer.
    Nisman B; Heching N; Biran H; Barak V; Peretz T
    Tumour Biol; 2006; 27(1):8-16. PubMed ID: 16340245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological and clinical significance of NAC1 expression in cervical carcinomas: a comparative study between squamous cell carcinomas and adenocarcinomas/adenosquamous carcinomas.
    Yeasmin S; Nakayama K; Rahman MT; Rahman M; Ishikawa M; Katagiri A; Iida K; Nakayama N; Otuski Y; Kobayashi H; Nakayama S; Miyazaki K
    Hum Pathol; 2012 Apr; 43(4):506-19. PubMed ID: 21889186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromogranin A gene expression in non-small cell lung carcinomas.
    Abbona G; Papotti M; Viberti L; Macrĭ L; Stella A; Bussolati G
    J Pathol; 1998 Oct; 186(2):151-6. PubMed ID: 9924430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuron-specific enolase and chromogranin A as markers of neuroendocrine tumours.
    Baudin E; Gigliotti A; Ducreux M; Ropers J; Comoy E; Sabourin JC; Bidart JM; Cailleux AF; Bonacci R; Ruffié P; Schlumberger M
    Br J Cancer; 1998 Oct; 78(8):1102-7. PubMed ID: 9792158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An immunohistochemical study of small-cell and poorly differentiated carcinomas of the cervix using neuroendocrine markers.
    Ueda G; Shimizu C; Shimizu H; Saito J; Tanaka Y; Inoue M; Tanizawa O
    Gynecol Oncol; 1989 Aug; 34(2):164-9. PubMed ID: 2473948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic significance of neuroendocrine markers and carcinoembryonic antigen in patients with resected stage I and II non-small cell lung cancer.
    Graziano SL; Tatum AH; Newman NB; Oler A; Kohman LJ; Veit LJ; Gamble GP; Coleman MJ; Barmada S; O'Lear S
    Cancer Res; 1994 Jun; 54(11):2908-13. PubMed ID: 8187076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroendocrine phenotype of non-small cell lung carcinoma: immunohistological evaluation and biochemical study.
    Slodkowska J; Zych J; Szturmowicz M; Demkow U; Rowinska-Zakrzewska E; Roszkowski-Sliz K
    Int J Biol Markers; 2005; 20(4):217-26. PubMed ID: 16398403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.